Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Antonietta Bacchiocchi"'
Autor:
Mario Sznol, Ruth Halaban, Yuval Shaked, Michal Harel, Coren Lahav, Eyal Jacob, Eran Issler, Haim Bar, Adam Dicker, Ofer Sharon, Antonietta Bacchiocchi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/5b561c7de1df4983af5ef64e4da9a888
Autor:
Heinrich Roder, Joanna Roder, Senait G. Asmellash, Julia Grigorieva, Krista Meyer, Carlos Oliveira, Mariaelena Capone, Paolo A. Ascierto, Antonietta Bacchiocchi, Ruth Halaban, Harriet M. Kluger, Genevieve Boland, Shauna Blackmon, Ryan J. Sullivan, Mario Sznol, Jeffrey S. Weber
Supplementary Figure 1: Schema of the hierarchical classifier development platform Supplementary Figure 2: Process for the simultaneous refinement of training class labels and classifier Supplementary Table 1: Association of Patient Characteristics w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1db2bb944ff8ec0f18db5d72a924d3e8
https://doi.org/10.1158/2326-6066.22537535
https://doi.org/10.1158/2326-6066.22537535
Autor:
Heinrich Roder, Joanna Roder, Senait G. Asmellash, Julia Grigorieva, Krista Meyer, Carlos Oliveira, Mariaelena Capone, Paolo A. Ascierto, Antonietta Bacchiocchi, Ruth Halaban, Harriet M. Kluger, Genevieve Boland, Shauna Blackmon, Ryan J. Sullivan, Mario Sznol, Jeffrey S. Weber
A mass spectrometry analysis was performed using serum from patients receiving checkpoint inhibitors to define baseline protein signatures associated with outcome in metastatic melanoma. Pretreatment serum was obtained from a development set of 119 m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca977cc3586b145de4ed509ab34319de
https://doi.org/10.1158/2326-6066.c.6548468.v1
https://doi.org/10.1158/2326-6066.c.6548468.v1
Autor:
Abul Usmani, Noah Earland, Wubing Zhang, Peter K. Harris, Antonietta Bacchiocchi, Aishwarya Nene, David Y. Chen, Mario Sznol, Ruth Halaban, Aaron M. Newman, Aadel A. Chaudhuri
Publikováno v:
Cancer Research. 83:6670-6670
Introduction: Severe immune-related adverse events (irAEs) occur in up to 60% of melanoma patients treated with immune checkpoint inhibitors (ICIs), causing substantial treatment-related morbidity and in the most severe cases, death. There is no clin
Autor:
Alexander X. Lozano, Aadel A. Chaudhuri, Aishwarya Nene, Antonietta Bacchiocchi, Noah Earland, Matthew D. Vesely, Abul Usmani, Brandon E. Turner, Chloé B. Steen, Bogdan A. Luca, Ti Badri, Gunsagar S. Gulati, Milad R. Vahid, Farnaz Khameneh, Peter K. Harris, David Y. Chen, Kavita Dhodapkar, Mario Sznol, Ruth Halaban, Aaron M. Newman
Publikováno v:
Nat Med
Severe immune-related adverse events (irAEs) occur in up to 60% of patients with melanoma treated with immune checkpoint inhibitors (ICIs). However, it is unknown whether a common baseline immunological state precedes irAE development. Here we applie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::975031290479ce416099f706a4316045
https://europepmc.org/articles/PMC8866214/
https://europepmc.org/articles/PMC8866214/
Autor:
Derek B. Lowe, Ming Wang, Soongyu Choi, Dixon Brian R, Peiying Liu, Christopher Town, Reina Natero, William J. Scott, David E. Gunn, Christiana Akuche, Cedo M. Bagi, Antonietta Bacchiocchi, Richard H. Kramss, Jill E. Wood, Ann-Marie Campbell, James H. Cook, Jeremy L. Baryza, Patricia Conrad, Yamin Wang, Catherine Brennan, Zhonghua Zhang, Ted Joe, Aniko Redman, Jeffrey Johnson, Todd Gane, Ehrlich Paul P, Joan Levy, Ian McAlexander, Jerold Jordan, Marie-Luise Blue
Publikováno v:
Bioorganicmedicinal chemistry letters. 16(18)
A series of 4,5-disubstituted cis-pyrrolidinones was investigated as inhibitors of 17beta-HSD II for the treatment of osteoporosis. Biochemical data for several compounds are given. Compound 42 was selected as the lead candidate.